Monday, 19 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

BEAULIEU-AV. CERT Stock Is 20% Up In The Last 5 Sessions

Loading stream...

(VIANEWS) - Shares of BEAULIEU-AV. CERT (BEL 20: BEAB.BR) jumped by a staggering 20.97% in 5 sessions from €4.34 to €5.25 at 14:07 EST on Friday, after two consecutive sessions in a row of gains. BEL 20 is dropping 0.22% to €3,633.36, after two consecutive sessions in a row of losses.

About BEAULIEU-AV. CERT

Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.

Volatility

BEAULIEU-AV. CERT's last week, last month's, and last quarter's current intraday variation average was a positive 5.26%, a negative 0.55%, and a positive 10.77%.

BEAULIEU-AV. CERT's highest amplitude of average volatility was 5.26% (last week), 11.28% (last month), and 10.77% (last quarter).

Volume

Today's last reported volume for BEAULIEU-AV. CERT is 50 which is 18.03% below its average volume of 61.

More news about BEAULIEU-AV. CERT (BEAB.BR).

Categories

stockMarket

Tags

BEAULIEU-AV. CERTStock PriceBEAB.BRMarket Session NowStock Market NowPrice UpMarket SessionStock Price UpStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,397 source documents archived
Query this data → isubstrate.com